Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primitive neuroectodermal tumors: ultrastructural and immunohistochemical studies

W Papierz1, J Alwasiak, P Kolasa

  • 1Department of Pathological Anatomy, Medical Academy Lodz, Poland.

Ultrastructural Pathology
|May 1, 1995
PubMed
Summary

Primitive neuroectodermal tumors (PNETs) show diverse neuroblastic differentiation. Electron microscopy and synaptophysin immunohistochemistry are key tools for detecting this differentiation in PNETs.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anti-tumor activity of the MDM2-TP53 inhibitor BI-907828 in dedifferentiated liposarcoma patient-derived xenograft models harboring MDM2 amplification.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2019
Same author

Exposure to Cryogenic Temperature and Exercises and Changes in Blood Pressure.

Cryo letters·2018
Same author

Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE'.

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same author

Activity and safety of crizotinib in patients with alveolar soft part sarcoma with rearrangement of TFE3: European Organization for Research and Treatment of Cancer (EORTC) phase II trial 90101 'CREATE'.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE'.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

Phalangeal chondrosarcoma: A rare presentation with an unusual biological behavior.

Hand surgery & rehabilitation·2017

Area of Science:

  • Neuroscience
  • Oncology
  • Pathology

Background:

  • Primitive neuroectodermal tumors (PNETs) are aggressive central nervous system neoplasms.
  • Understanding neuroblastic differentiation in PNETs is crucial for accurate diagnosis and prognosis.

Purpose of the Study:

  • To investigate the ultrastructural and immunohistochemical features of neuroblastic differentiation in PNETs.
  • To evaluate the reliability of different markers for detecting neuroblastic differentiation.

Main Methods:

  • Ultrastructural analysis using electron microscopy on 17 retrospective and 26 prospective PNET specimens.
  • Immunohistochemical staining for synaptophysin, 200 kDa neurofilament protein, and glial fibrillary acidic protein (GFAP).

Main Results:

Related Experiment Videos

  • Electron microscopy revealed neuritelike structures in most PNETs, with rare synaptic specializations.
  • Synaptophysin was the most consistent marker for neuroblastic differentiation, present in the majority of tumors.
  • 200 kDa neurofilament protein and GFAP showed variable expression patterns.

Conclusions:

  • The majority of PNETs exhibit diverse differentiation.
  • Electron microscopy remains the most reliable method for detecting neuroblastic differentiation in PNETs.
  • Immunohistochemistry for synaptophysin is a valuable secondary diagnostic tool.